Prognostic Value Of Natriuretic Peptide Levels For Adverse Renal Outcomes In Patients With Moderate To Severe Acute Kidney Injury With Or Without Heart Failure
Thanat Chaikijurajai,Sevag Demirjian,Wai Hong Tang
DOI: https://doi.org/10.1016/j.cardfail.2023.10.128
IF: 6.592
2024-01-01
Journal of Cardiac Failure
Abstract:Introduction Natriuretic peptides have been recommended as biomarkers for the diagnosis and prognosis of patients with HF, and are often elevated the setting of acute kidney injury (AKI). However, the prognostic value of NT-proBNP in patients with AKI with or without HF remains unclear. Hypothesis Increased NT-proBNP on admission was associated with adverse renal outcomes (need for dialysis, dialysis dependence, and in-hospital mortality) in patients with AKI regardless of HF diagnosis. Methods We retrospectively reviewed electronic medical records of consecutive patients with AKI stage 2 and 3 admitted to the Cleveland Clinic between September 2011 and December 2021. Patients with NT-proBNP levels collected before renal consultation or dialysis initiation were included. We excluded patients without baseline creatinine prior to index hospitalization, or with ESRD, kidney transplant or long-tern dialysis. Outcomes were dialysis requirement and dialysis dependence defined as patients undergoing dialysis within 72 hours prior to hospital discharge, or in-hospital mortality. Multivariable logistic regression analysis was used to determine prognostic value of NT-proBNP levels with adjustment for cardio-renal risk factors including age, race, sex, baseline CKD stage, CAD, HF, hypertension, diabetes, presence of LV systolic dysfunction (EF ≤ 40%), cirrhosis, cancer, surgery during index hospitalization, mechanical ventilation, sepsis, and type of AKI (community- or hospital-acquired). Results In our study cohort (n=3,811, median [IQR] age 66 [56-74] years, baseline Cr 1.06 [0.80-1.49] mg/dL, peak Cr 3.66 [2.76-4.86], and NT-proBNP 6,418 [2,002-18,215] pg/mL), 2,521 (66%) patients underwent dialysis, and 1,619 (42%) patients became dialysis dependent, and 1,325 (35%) patients had in-hospital mortality. After adjusting for cardio-renal risk factors, the highest quartile of NT-proBNP (≥18,215 pg/ml) was associated with increased likelihood of dialysis requirement (quartile [Q] 4 vs 1; odds ratio [OR]: 2.36; 95% CI: 1.87 to 2.99), becoming dialysis dependence (Q4 vs 1; OR: 1.46; 95% CI: 1.08 to 2.00), and had mortality (Q4 vs 1; OR: 1.34; 95% CI: 1.01 to 1.34). Prognostic value of NT-proBNP levels remained robust for dialysis requirement and dependence in subgroups of patients with HF (n=1,966) and without HF (n=1,845) with P for interaction 0.780 and 0.200, respectively (Figure 1), but not for mortality in patients with HF (P for interaction 0.007, Figure 1A). Conclusions Increased NT-proBNP was independently associated with an increased risk of dialysis requirement and becoming dialysis dependence and in-hospital mortality in patients with moderate to severe AKI with or without HF.
cardiac & cardiovascular systems